https://www.selleckchem.com/pr....oducts/itacitinib-in
40 for LA 47 vs≤47%, 95% CI 0.01; 0.78; p=0.046). Associations of plasma LA with annual eGFR decline were stronger in 437 patients with diabetes (1.21, 0.24; 2.19) and in 402 patients with CKD (eGFR60; 0.90, -0.09; 1.89). Weaker, non-significant associations with kidney function decline were observed for the other plasma FAs. Higher plasma LA may be a good predictor of less kidney function decline after MI, particularly in patients with diabetes. The Alpha Omega Cohort is registered with clinicaltrials.gov, NCT03192
پسندیدن
اظهار نظر
اشتراک گذاری
